Cargando…

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis

BACKGROUND: Considering the heavy economic burden of osteoporotic fractures, the limits of healthcare resources, and the recent availability of new anti-osteoporosis drugs, there is continuing interest in economic evaluation studies of osteoporosis management strategies. OBJECTIVES: This study aims...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Nannan, Cornelissen, Dennis, Silverman, Stuart, Pinto, Daniel, Si, Lei, Kremer, Ingrid, Bours, Sandrine, de Bot, Robin, Boonen, Annelies, Evers, Silvia, van den Bergh, Joop, Reginster, Jean-Yves, Hiligsmann, Mickaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867562/ https://www.ncbi.nlm.nih.gov/pubmed/33026634 http://dx.doi.org/10.1007/s40273-020-00965-9

Ejemplares similares

A Review of Patient Preferences for Osteoporosis Drug Treatment
por: Hiligsmann, Mickaël, et al.
Publicado: (2015)

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review
por: Cornelissen, D., et al.
Publicado: (2020)

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Improvement of osteoporosis Care Organized by Nurses: ICON study - Protocol of a quasi-experimental study to assess the (cost)-effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service
por: Cornelissen, Dennis, et al.
Publicado: (2021)

Understanding patients’ preferences for osteoporosis treatment: the impact of patients’ characteristics on subgroups and latent classes
por: Cornelissen, D., et al.
Publicado: (2019)

The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2020)

A model-based cost-effectiveness analysis of fracture liaison services in China
por: Li, Nannan, et al.
Publicado: (2022)

Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
por: Hiligsmann, Mickaël, et al.
Publicado: (2014)

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Economic Burden of Multiple Sclerosis in Low- and Middle‐Income Countries: A Systematic Review
por: Dahham, Jalal, et al.
Publicado: (2021)

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Optimal Use of Vitamin D When Treating Osteoporosis
por: van den Bergh, Joop P. W., et al.
Publicado: (2010)

Patients’ Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments
por: Bien, Daniela R., et al.
Publicado: (2017)

FRI682 Cost Effectiveness Of Four Treatment Approaches For US Women And Men At Very High Risk Of Osteoporotic Fractures
por: Hiligsmann, Mickael, et al.
Publicado: (2023)

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
por: Hiligsmann, M., et al.
Publicado: (2019)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
por: Hiligsmann, Mickaël, et al.
Publicado: (2023)

A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment
por: Beaudart, Charlotte, et al.
Publicado: (2022)

Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review
por: Beaudart, Charlotte, et al.
Publicado: (2021)

The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis
por: Li, N., et al.
Publicado: (2021)

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
por: Hiligsmann, M., et al.
Publicado: (2013)

Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures
por: Ethgen, Olivier, et al.
Publicado: (2015)

Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling
por: Kremer, Ingrid E. H., et al.
Publicado: (2017)

The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis
por: Hiligsmann, M., et al.
Publicado: (2016)

Using Best–Worst Scaling to Investigate Preferences in Health Care
por: Cheung, Kei Long, et al.
Publicado: (2016)

A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention
por: Hiligsmann, Mickael, et al.
Publicado: (2017)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
por: Chandran, M., et al.
Publicado: (2020)

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
por: Hiligsmann, M., et al.
Publicado: (2021)

Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
por: Heinz, Katja C., et al.
Publicado: (2023)

Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment
por: Beaudart, C., et al.
Publicado: (2022)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI
por: Essers, Ivette, et al.
Publicado: (2019)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Health-related quality of life of patients with a recent fracture attending a fracture liaison service: a 3-year follow-up study
por: Li, N., et al.
Publicado: (2021)

Efficacy of Bracing on Thoracic Kyphotic Angle and Functionality in Women with Osteoporosis: A Systematic Review
por: Sánchez-Pinto-Pinto, Beatriz, et al.
Publicado: (2022)

Osteoporosis and sarcopenia: two diseases or one?
por: Reginster, Jean-Yves, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b074c94cba6h99ks2re3dtf9q3